The calculus of variations in the large

por Morse, M
Publicado 1934

Perspectives in cancer chemoprevention.

por Stoner, G D, Morse, M A, Kelloff, G J
Publicado 1997

Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect.

por Carlson, G P, Fossa, A A, Morse, M A, Weaver, P M
Publicado 1986

The Management and Supervision Tool (MaST): an electronic crisis risk prediction tool to support safe and effective mental healthcare

por Patel, R., Oram, J., Hebden, N., Payne, Z., Morse, M., Gadd, C.
Publicado 2022

X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity

por Evans, M K, Sauer, S J, Nath, S, Robinson, T J, Morse, M A, Devi, G R
Publicado 2016

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody

por Osada, T, Hsu, D, Hammond, S, Hobeika, A, Devi, G, Clay, T M, Lyerly, H K, Morse, M A
Publicado 2010

trips4health: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain

por Sharman, M.J., Ball, K., Greaves, S., Jose, K.A., Morse, M., Blizzard, C.L., Wells, G., Venn, A.J., Palmer, A.J., Lester, D., Williams, J., Harpur, S., Cleland, V.J.
Publicado 2020

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM(SM) registry

por Fishman, M., Dutcher, J. P., Clark, J. I., Alva, A., Miletello, G. P., Curti, B., Agarwal, Neeraj, Hauke, R., Mahoney, K. M., Moon, H., Treisman, J., Tykodi, S. S., Daniels, G., Morse, M. A., Wong, M. K. K., Kaufman, H., Gregory, N., McDermott, D. F.
Publicado 2019